Compound: Dactolisib

Drug Target: PI3K (class 1), MTORC1, MTORC2

Drug Target pathway: PI3K/MTOR signaling

Dataset



Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.